Aims
Recent Progress in Tumor is an international peer-reviewed Open Access journal that covers all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics, and management strategies. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Recent Progress in Tumor is committed to advancing developments in the field by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.
Topics contain but are not limited to:
- Breast Cancer
- Cardiac Oncology
- Gastrointestinal Cancer
- Pancreatic Cancer
- Genitourinary Oncology
- Gynecologic Oncology
- Head and Neck Cancer
- Thoracic Oncology
- Oral Cancer
- Nasopharyngeal Cancer
- Hematologic Malignancies
- Bone Cancer
- Radiation Oncology
- Skin Cancer
- Childhood Cancer
- Surgical Oncology
- Cancer Cell Signaling
- Cancer Epidemiology and Prevention
- Cancer Genetics
- Cancer Imaging & Image-Guided Interventions
- Cancer Immunology & Immunotherapy
- Radiation Therapy
- Cancer Metabolism
- Cancer Molecular Targets and Therapy
- Molecular and Cellular Oncology
- Neuro-Oncology and Neurosurgical Oncology
- Anti-cancer Drug Pharmacology
- Tumors and Pregnancy
- Cancer - Living with Cancer
It publishes a variety of article types: Research Articles, Review, Communication, etc.
There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Ethics Statement
Recent Progress in Tumor is a member of the Committee on Publication Ethics (COPE). Science Publication Inc. takes the responsibility to enforce a rigorous peer-review process together with strict ethical policies and standards to enforce high-quality articles. To verify the originality of content submitted to our journals, we run an assay using iThenticate to check the similarity of submissions against previous published works.
All manuscripts submitted to Recent Progress in Tumor that have been conducted in human subjects must conform with current regulations and the Declaration of Helsinki. Ethics committee approval and informed patient consent are required for studies involving human subjects. Ethics committee approval is also needed for studies involving animals.
Announcement and Advertisement
Announcements regarding academic conferences are published for free in the Conferences section of the journal. Advertisement can be either published or placed on the pertinent website. Please contact at [email protected]